M3, Inc.
M3, Inc. MTHRF Peers
See (MTHRF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MTHRF | $13.65 | +0.00% | 9.3B | 33.29 | $0.41 | +1.03% |
| PMCUF | $185.40 | +0.22% | 19.4B | 303.93 | $0.61 | +0.16% |
| MTHRY | $6.67 | -0.30% | 9.1B | 31.90 | $0.21 | N/A |
| PANHF | $0.91 | +0.00% | 2B | 90.90 | $0.01 | +137.13% |
| PIAHY | $2.29 | +0.00% | 1.2B | 114.50 | $0.02 | +108.54% |
| CMPVF | $23.75 | -0.44% | 1.2B | 40.95 | $0.58 | +4.21% |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| RSLBF | $32.05 | +0.00% | 1.1B | 47.84 | $0.67 | +0.98% |
| CRWRF | $29.25 | +0.00% | 1B | 69.64 | $0.42 | +1.29% |
| SUSRF | $15.10 | +0.00% | 770.5M | 52.07 | $0.29 | N/A |
Stock Comparison
MTHRF vs PMCUF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, PMCUF has a market cap of 19.4B. Regarding current trading prices, MTHRF is priced at $13.65, while PMCUF trades at $185.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas PMCUF's P/E ratio is 303.93. In terms of profitability, MTHRF's ROE is +0.09%, compared to PMCUF's ROE of +0.48%. Regarding short-term risk, MTHRF is more volatile compared to PMCUF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs MTHRY Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, MTHRY has a market cap of 9.1B. Regarding current trading prices, MTHRF is priced at $13.65, while MTHRY trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas MTHRY's P/E ratio is 31.90. In terms of profitability, MTHRF's ROE is +0.09%, compared to MTHRY's ROE of +0.09%. Regarding short-term risk, MTHRF is more volatile compared to MTHRY. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs PANHF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, PANHF has a market cap of 2B. Regarding current trading prices, MTHRF is priced at $13.65, while PANHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas PANHF's P/E ratio is 90.90. In terms of profitability, MTHRF's ROE is +0.09%, compared to PANHF's ROE of -0.00%. Regarding short-term risk, MTHRF is more volatile compared to PANHF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs PIAHY Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, PIAHY has a market cap of 1.2B. Regarding current trading prices, MTHRF is priced at $13.65, while PIAHY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas PIAHY's P/E ratio is 114.50. In terms of profitability, MTHRF's ROE is +0.09%, compared to PIAHY's ROE of -0.00%. Regarding short-term risk, MTHRF is more volatile compared to PIAHY. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CMPVF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CMPVF has a market cap of 1.2B. Regarding current trading prices, MTHRF is priced at $13.65, while CMPVF trades at $23.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CMPVF's P/E ratio is 40.95. In terms of profitability, MTHRF's ROE is +0.09%, compared to CMPVF's ROE of +0.04%. Regarding short-term risk, MTHRF is more volatile compared to CMPVF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CMPUY Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, MTHRF is priced at $13.65, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, MTHRF's ROE is +0.09%, compared to CMPUY's ROE of +0.04%. Regarding short-term risk, MTHRF is more volatile compared to CMPUY. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs RSLBF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, RSLBF has a market cap of 1.1B. Regarding current trading prices, MTHRF is priced at $13.65, while RSLBF trades at $32.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas RSLBF's P/E ratio is 47.84. In terms of profitability, MTHRF's ROE is +0.09%, compared to RSLBF's ROE of +0.26%. Regarding short-term risk, MTHRF is more volatile compared to RSLBF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CRWRF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CRWRF has a market cap of 1B. Regarding current trading prices, MTHRF is priced at $13.65, while CRWRF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CRWRF's P/E ratio is 69.64. In terms of profitability, MTHRF's ROE is +0.09%, compared to CRWRF's ROE of +0.04%. Regarding short-term risk, MTHRF is more volatile compared to CRWRF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs SUSRF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, SUSRF has a market cap of 770.5M. Regarding current trading prices, MTHRF is priced at $13.65, while SUSRF trades at $15.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas SUSRF's P/E ratio is 52.07. In terms of profitability, MTHRF's ROE is +0.09%, compared to SUSRF's ROE of +0.03%. Regarding short-term risk, MTHRF is more volatile compared to SUSRF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs SMSZF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, SMSZF has a market cap of 727.3M. Regarding current trading prices, MTHRF is priced at $13.65, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas SMSZF's P/E ratio is 17.47. In terms of profitability, MTHRF's ROE is +0.09%, compared to SMSZF's ROE of +0.20%. Regarding short-term risk, MTHRF is more volatile compared to SMSZF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs VHIBF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, VHIBF has a market cap of 433.8M. Regarding current trading prices, MTHRF is priced at $13.65, while VHIBF trades at $8.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas VHIBF's P/E ratio is 267.83. In terms of profitability, MTHRF's ROE is +0.09%, compared to VHIBF's ROE of +0.02%. Regarding short-term risk, MTHRF is more volatile compared to VHIBF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs KSIOF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, KSIOF has a market cap of 412.9M. Regarding current trading prices, MTHRF is priced at $13.65, while KSIOF trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas KSIOF's P/E ratio is -218.70. In terms of profitability, MTHRF's ROE is +0.09%, compared to KSIOF's ROE of -0.05%. Regarding short-term risk, MTHRF is more volatile compared to KSIOF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs SMDCF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, MTHRF is priced at $13.65, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, MTHRF's ROE is +0.09%, compared to SMDCF's ROE of N/A. Regarding short-term risk, MTHRF is more volatile compared to SMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs DLHTF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, MTHRF is priced at $13.65, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, MTHRF's ROE is +0.09%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, MTHRF is more volatile compared to DLHTF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs COGZF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, COGZF has a market cap of 202.7M. Regarding current trading prices, MTHRF is priced at $13.65, while COGZF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas COGZF's P/E ratio is 30.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to COGZF's ROE of +0.17%. Regarding short-term risk, MTHRF is more volatile compared to COGZF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs VPAHF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, MTHRF is priced at $13.65, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, MTHRF is more volatile compared to VPAHF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs ACMLF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, ACMLF has a market cap of 150.9M. Regarding current trading prices, MTHRF is priced at $13.65, while ACMLF trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas ACMLF's P/E ratio is 35.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to ACMLF's ROE of +0.21%. Regarding short-term risk, MTHRF is less volatile compared to ACMLF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs ONVVF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, ONVVF has a market cap of 133.1M. Regarding current trading prices, MTHRF is priced at $13.65, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to ONVVF's ROE of -0.97%. Regarding short-term risk, MTHRF is more volatile compared to ONVVF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CSAMF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, MTHRF is priced at $13.65, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, MTHRF's ROE is +0.09%, compared to CSAMF's ROE of -1.58%. Regarding short-term risk, MTHRF is more volatile compared to CSAMF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs MDPEF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, MDPEF has a market cap of 61.3M. Regarding current trading prices, MTHRF is priced at $13.65, while MDPEF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas MDPEF's P/E ratio is 6.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to MDPEF's ROE of N/A. Regarding short-term risk, MTHRF is less volatile compared to MDPEF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs HITC Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, MTHRF is priced at $13.65, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas HITC's P/E ratio is -14.75. In terms of profitability, MTHRF's ROE is +0.09%, compared to HITC's ROE of -1.29%. Regarding short-term risk, MTHRF is more volatile compared to HITC. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs RQHTF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, RQHTF has a market cap of 30.4M. Regarding current trading prices, MTHRF is priced at $13.65, while RQHTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, MTHRF's ROE is +0.09%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, MTHRF is less volatile compared to RQHTF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs RTNXF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, MTHRF is priced at $13.65, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, MTHRF's ROE is +0.09%, compared to RTNXF's ROE of +2.93%. Regarding short-term risk, MTHRF is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs TREIF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, TREIF has a market cap of 22.1M. Regarding current trading prices, MTHRF is priced at $13.65, while TREIF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas TREIF's P/E ratio is -2.09. In terms of profitability, MTHRF's ROE is +0.09%, compared to TREIF's ROE of -11.21%. Regarding short-term risk, MTHRF is more volatile compared to TREIF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs VASO Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, VASO has a market cap of 22M. Regarding current trading prices, MTHRF is priced at $13.65, while VASO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas VASO's P/E ratio is 12.51. In terms of profitability, MTHRF's ROE is +0.09%, compared to VASO's ROE of +0.04%. Regarding short-term risk, MTHRF is more volatile compared to VASO. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs HDSLF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, MTHRF is priced at $13.65, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, MTHRF's ROE is +0.09%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, MTHRF is more volatile compared to HDSLF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs THKKF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, MTHRF is priced at $13.65, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas THKKF's P/E ratio is -1.51. In terms of profitability, MTHRF's ROE is +0.09%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, MTHRF is more volatile compared to THKKF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs DGNOF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, DGNOF has a market cap of 15.7M. Regarding current trading prices, MTHRF is priced at $13.65, while DGNOF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas DGNOF's P/E ratio is -3.85. In terms of profitability, MTHRF's ROE is +0.09%, compared to DGNOF's ROE of +2.18%. Regarding short-term risk, MTHRF is more volatile compared to DGNOF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs MDBIF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, MDBIF has a market cap of 15.1M. Regarding current trading prices, MTHRF is priced at $13.65, while MDBIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas MDBIF's P/E ratio is -2.43. In terms of profitability, MTHRF's ROE is +0.09%, compared to MDBIF's ROE of -0.14%. Regarding short-term risk, MTHRF is more volatile compared to MDBIF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs MNNDF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, MTHRF is priced at $13.65, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, MTHRF's ROE is +0.09%, compared to MNNDF's ROE of N/A. Regarding short-term risk, MTHRF is more volatile compared to MNNDF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs PBSV Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, PBSV has a market cap of 13.8M. Regarding current trading prices, MTHRF is priced at $13.65, while PBSV trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas PBSV's P/E ratio is -60.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, MTHRF is more volatile compared to PBSV. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CRVW Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CRVW has a market cap of 11.7M. Regarding current trading prices, MTHRF is priced at $13.65, while CRVW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CRVW's P/E ratio is -2.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to CRVW's ROE of +0.16%. Regarding short-term risk, MTHRF is more volatile compared to CRVW. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs UDOCF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, UDOCF has a market cap of 10.7M. Regarding current trading prices, MTHRF is priced at $13.65, while UDOCF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas UDOCF's P/E ratio is -2.33. In terms of profitability, MTHRF's ROE is +0.09%, compared to UDOCF's ROE of +6.57%. Regarding short-term risk, MTHRF is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CDXFF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, MTHRF is priced at $13.65, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, MTHRF's ROE is +0.09%, compared to CDXFF's ROE of +0.44%. Regarding short-term risk, MTHRF is more volatile compared to CDXFF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs HSCHF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, HSCHF has a market cap of 9.5M. Regarding current trading prices, MTHRF is priced at $13.65, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas HSCHF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to HSCHF's ROE of +0.00%. Regarding short-term risk, MTHRF is more volatile compared to HSCHF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs VYND Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, VYND has a market cap of 9.2M. Regarding current trading prices, MTHRF is priced at $13.65, while VYND trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas VYND's P/E ratio is -49.99. In terms of profitability, MTHRF's ROE is +0.09%, compared to VYND's ROE of +0.48%. Regarding short-term risk, MTHRF is more volatile compared to VYND. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs HBCNF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, MTHRF is priced at $13.65, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, MTHRF's ROE is +0.09%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, MTHRF is more volatile compared to HBCNF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs SPLTF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, MTHRF is priced at $13.65, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, MTHRF's ROE is +0.09%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, MTHRF is more volatile compared to SPLTF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs AIMLF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, AIMLF has a market cap of 7.5M. Regarding current trading prices, MTHRF is priced at $13.65, while AIMLF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas AIMLF's P/E ratio is -1.07. In terms of profitability, MTHRF's ROE is +0.09%, compared to AIMLF's ROE of -11.81%. Regarding short-term risk, MTHRF is more volatile compared to AIMLF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CRBKF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, MTHRF is priced at $13.65, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, MTHRF's ROE is +0.09%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, MTHRF is more volatile compared to CRBKF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs EMOR Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, EMOR has a market cap of 6.6M. Regarding current trading prices, MTHRF is priced at $13.65, while EMOR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas EMOR's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to EMOR's ROE of +0.28%. Regarding short-term risk, MTHRF is more volatile compared to EMOR. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs DOCRF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, MTHRF is priced at $13.65, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, MTHRF's ROE is +0.09%, compared to DOCRF's ROE of -2.21%. Regarding short-term risk, MTHRF is more volatile compared to DOCRF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CNONF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CNONF has a market cap of 5M. Regarding current trading prices, MTHRF is priced at $13.65, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CNONF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, MTHRF is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs RYAHF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, RYAHF has a market cap of 5M. Regarding current trading prices, MTHRF is priced at $13.65, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, MTHRF's ROE is +0.09%, compared to RYAHF's ROE of +0.00%. Regarding short-term risk, MTHRF is more volatile compared to RYAHF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs IQAIF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, MTHRF is priced at $13.65, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas IQAIF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to IQAIF's ROE of -1.62%. Regarding short-term risk, MTHRF is more volatile compared to IQAIF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CMPD Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CMPD has a market cap of 4.4M. Regarding current trading prices, MTHRF is priced at $13.65, while CMPD trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CMPD's P/E ratio is -15.30. In terms of profitability, MTHRF's ROE is +0.09%, compared to CMPD's ROE of +0.07%. Regarding short-term risk, MTHRF is more volatile compared to CMPD. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs LVCE Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, LVCE has a market cap of 4.3M. Regarding current trading prices, MTHRF is priced at $13.65, while LVCE trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas LVCE's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to LVCE's ROE of N/A. Regarding short-term risk, MTHRF is more volatile compared to LVCE. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CBDS Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, MTHRF is priced at $13.65, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CBDS's P/E ratio is -1.48. In terms of profitability, MTHRF's ROE is +0.09%, compared to CBDS's ROE of +1.55%. Regarding short-term risk, MTHRF is more volatile compared to CBDS. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CTVEF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CTVEF has a market cap of 3.9M. Regarding current trading prices, MTHRF is priced at $13.65, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, MTHRF's ROE is +0.09%, compared to CTVEF's ROE of +0.08%. Regarding short-term risk, MTHRF is more volatile compared to CTVEF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs EKGGF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, EKGGF has a market cap of 3.3M. Regarding current trading prices, MTHRF is priced at $13.65, while EKGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas EKGGF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to EKGGF's ROE of +0.54%. Regarding short-term risk, MTHRF is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs MITI Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, MITI has a market cap of 3.2M. Regarding current trading prices, MTHRF is priced at $13.65, while MITI trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas MITI's P/E ratio is -9.33. In terms of profitability, MTHRF's ROE is +0.09%, compared to MITI's ROE of -0.05%. Regarding short-term risk, MTHRF is more volatile compared to MITI. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CMHSF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CMHSF has a market cap of 2.2M. Regarding current trading prices, MTHRF is priced at $13.65, while CMHSF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CMHSF's P/E ratio is 1.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to CMHSF's ROE of +0.10%. Regarding short-term risk, MTHRF is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs EBYH Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, EBYH has a market cap of 2.1M. Regarding current trading prices, MTHRF is priced at $13.65, while EBYH trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas EBYH's P/E ratio is -6.10. In terms of profitability, MTHRF's ROE is +0.09%, compared to EBYH's ROE of -0.03%. Regarding short-term risk, MTHRF is more volatile compared to EBYH. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs BNVIF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, BNVIF has a market cap of 1.7M. Regarding current trading prices, MTHRF is priced at $13.65, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas BNVIF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, MTHRF is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs MDXL Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, MDXL has a market cap of 801K. Regarding current trading prices, MTHRF is priced at $13.65, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas MDXL's P/E ratio is -0.10. In terms of profitability, MTHRF's ROE is +0.09%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, MTHRF is more volatile compared to MDXL. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs DTRK Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, DTRK has a market cap of 680.8K. Regarding current trading prices, MTHRF is priced at $13.65, while DTRK trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas DTRK's P/E ratio is -4.84. In terms of profitability, MTHRF's ROE is +0.09%, compared to DTRK's ROE of -9.79%. Regarding short-term risk, MTHRF is more volatile compared to DTRK. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs NEWUF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, NEWUF has a market cap of 634.6K. Regarding current trading prices, MTHRF is priced at $13.65, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas NEWUF's P/E ratio is -0.03. In terms of profitability, MTHRF's ROE is +0.09%, compared to NEWUF's ROE of +0.67%. Regarding short-term risk, MTHRF is more volatile compared to NEWUF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs EVAHF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, EVAHF has a market cap of 557.6K. Regarding current trading prices, MTHRF is priced at $13.65, while EVAHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas EVAHF's P/E ratio is -4.80. In terms of profitability, MTHRF's ROE is +0.09%, compared to EVAHF's ROE of +0.29%. Regarding short-term risk, MTHRF is more volatile compared to EVAHF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs MDRM Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, MDRM has a market cap of 535.7K. Regarding current trading prices, MTHRF is priced at $13.65, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas MDRM's P/E ratio is -0.42. In terms of profitability, MTHRF's ROE is +0.09%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, MTHRF is less volatile compared to MDRM. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs MDNWF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, MTHRF is priced at $13.65, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, MTHRF's ROE is +0.09%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, MTHRF is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CSOC Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CSOC has a market cap of 498.1K. Regarding current trading prices, MTHRF is priced at $13.65, while CSOC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CSOC's P/E ratio is 0.18. In terms of profitability, MTHRF's ROE is +0.09%, compared to CSOC's ROE of -2.38%. Regarding short-term risk, MTHRF is less volatile compared to CSOC. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs TSTTF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, TSTTF has a market cap of 461.3K. Regarding current trading prices, MTHRF is priced at $13.65, while TSTTF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas TSTTF's P/E ratio is -1.67. In terms of profitability, MTHRF's ROE is +0.09%, compared to TSTTF's ROE of +0.33%. Regarding short-term risk, MTHRF is less volatile compared to TSTTF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs NDATF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, NDATF has a market cap of 450.5K. Regarding current trading prices, MTHRF is priced at $13.65, while NDATF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas NDATF's P/E ratio is -0.55. In terms of profitability, MTHRF's ROE is +0.09%, compared to NDATF's ROE of -0.62%. Regarding short-term risk, MTHRF is more volatile compared to NDATF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs ACHKF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, MTHRF is priced at $13.65, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, MTHRF's ROE is +0.09%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, MTHRF is more volatile compared to ACHKF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs NHIQ Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, NHIQ has a market cap of 302.2K. Regarding current trading prices, MTHRF is priced at $13.65, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas NHIQ's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, MTHRF is more volatile compared to NHIQ. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs LFCOF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, LFCOF has a market cap of 282K. Regarding current trading prices, MTHRF is priced at $13.65, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, MTHRF's ROE is +0.09%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, MTHRF is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs ALDNF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, MTHRF is priced at $13.65, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas ALDNF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to ALDNF's ROE of +0.00%. Regarding short-term risk, MTHRF is more volatile compared to ALDNF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs USPS Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, USPS has a market cap of 158.5K. Regarding current trading prices, MTHRF is priced at $13.65, while USPS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas USPS's P/E ratio is -1.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to USPS's ROE of -0.63%. Regarding short-term risk, MTHRF is more volatile compared to USPS. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs EMYSF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, EMYSF has a market cap of 151.7K. Regarding current trading prices, MTHRF is priced at $13.65, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas EMYSF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to EMYSF's ROE of +0.00%. Regarding short-term risk, MTHRF is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs DSOL Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, DSOL has a market cap of 88.9K. Regarding current trading prices, MTHRF is priced at $13.65, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas DSOL's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to DSOL's ROE of +0.05%. Regarding short-term risk, MTHRF is more volatile compared to DSOL. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs ICCO Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, ICCO has a market cap of 71.7K. Regarding current trading prices, MTHRF is priced at $13.65, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas ICCO's P/E ratio is -0.40. In terms of profitability, MTHRF's ROE is +0.09%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, MTHRF is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs REFG Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, MTHRF is priced at $13.65, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas REFG's P/E ratio is -0.01. In terms of profitability, MTHRF's ROE is +0.09%, compared to REFG's ROE of +0.01%. Regarding short-term risk, MTHRF is more volatile compared to REFG. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs HDVY Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, MTHRF is priced at $13.65, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas HDVY's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to HDVY's ROE of +0.00%. Regarding short-term risk, MTHRF is more volatile compared to HDVY. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs IGRW Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, MTHRF is priced at $13.65, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas IGRW's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to IGRW's ROE of +7.88%. Regarding short-term risk, MTHRF is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs RVRC Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, RVRC has a market cap of 39.2K. Regarding current trading prices, MTHRF is priced at $13.65, while RVRC trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas RVRC's P/E ratio is -0.11. In terms of profitability, MTHRF's ROE is +0.09%, compared to RVRC's ROE of -0.29%. Regarding short-term risk, MTHRF is more volatile compared to RVRC. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs WMGR Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, MTHRF is priced at $13.65, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas WMGR's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to WMGR's ROE of +0.00%. Regarding short-term risk, MTHRF is less volatile compared to WMGR. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs SSYNF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, MTHRF is priced at $13.65, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to SSYNF's ROE of N/A. Regarding short-term risk, MTHRF is more volatile compared to SSYNF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs SOFE Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, SOFE has a market cap of 31K. Regarding current trading prices, MTHRF is priced at $13.65, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas SOFE's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, MTHRF is more volatile compared to SOFE. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs TTBLF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, MTHRF is priced at $13.65, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, MTHRF is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs ORHB Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, ORHB has a market cap of 25.6K. Regarding current trading prices, MTHRF is priced at $13.65, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas ORHB's P/E ratio is -0.01. In terms of profitability, MTHRF's ROE is +0.09%, compared to ORHB's ROE of +0.33%. Regarding short-term risk, MTHRF is more volatile compared to ORHB. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs EWLL Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, EWLL has a market cap of 18.5K. Regarding current trading prices, MTHRF is priced at $13.65, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas EWLL's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to EWLL's ROE of +0.00%. Regarding short-term risk, MTHRF is more volatile compared to EWLL. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs NHEL Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, MTHRF is priced at $13.65, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas NHEL's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to NHEL's ROE of +0.00%. Regarding short-term risk, MTHRF is more volatile compared to NHEL. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs FDBH Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, FDBH has a market cap of 15K. Regarding current trading prices, MTHRF is priced at $13.65, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas FDBH's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, MTHRF is more volatile compared to FDBH. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs HLTT Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, MTHRF is priced at $13.65, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas HLTT's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, MTHRF is more volatile compared to HLTT. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs PPJE Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, PPJE has a market cap of 9.2K. Regarding current trading prices, MTHRF is priced at $13.65, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas PPJE's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to PPJE's ROE of +0.00%. Regarding short-term risk, MTHRF is less volatile compared to PPJE. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs CGNSF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, MTHRF is priced at $13.65, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas CGNSF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, MTHRF is less volatile compared to CGNSF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs MOSTQ Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, MTHRF is priced at $13.65, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, MTHRF's ROE is +0.09%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, MTHRF is more volatile compared to MOSTQ. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs ACNV Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, MTHRF is priced at $13.65, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas ACNV's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to ACNV's ROE of +0.00%. Regarding short-term risk, MTHRF is more volatile compared to ACNV. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs AHGIF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, MTHRF is priced at $13.65, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas AHGIF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, MTHRF is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs NMXS Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, NMXS has a market cap of 3.8K. Regarding current trading prices, MTHRF is priced at $13.65, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas NMXS's P/E ratio is -0.01. In terms of profitability, MTHRF's ROE is +0.09%, compared to NMXS's ROE of +1.59%. Regarding short-term risk, MTHRF is more volatile compared to NMXS. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs BBLNF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, MTHRF is priced at $13.65, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas BBLNF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, MTHRF is more volatile compared to BBLNF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs PCYS Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, MTHRF is priced at $13.65, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas PCYS's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, MTHRF is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs OLMM Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, MTHRF is priced at $13.65, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas OLMM's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to OLMM's ROE of +0.00%. Regarding short-term risk, MTHRF is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs PASO Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, PASO has a market cap of 741. Regarding current trading prices, MTHRF is priced at $13.65, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas PASO's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to PASO's ROE of +6.20%. Regarding short-term risk, MTHRF is more volatile compared to PASO. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs ETAOF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, ETAOF has a market cap of 512. Regarding current trading prices, MTHRF is priced at $13.65, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas ETAOF's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, MTHRF is less volatile compared to ETAOF. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs LGBI Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, LGBI has a market cap of 50. Regarding current trading prices, MTHRF is priced at $13.65, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas LGBI's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, MTHRF is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs APYI Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, APYI has a market cap of 34. Regarding current trading prices, MTHRF is priced at $13.65, while APYI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas APYI's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to APYI's ROE of -0.60%. Regarding short-term risk, MTHRF is more volatile compared to APYI. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs VMCS Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, VMCS has a market cap of 0. Regarding current trading prices, MTHRF is priced at $13.65, while VMCS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas VMCS's P/E ratio is N/A. In terms of profitability, MTHRF's ROE is +0.09%, compared to VMCS's ROE of +3.10%. Regarding short-term risk, MTHRF is more volatile compared to VMCS. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.
MTHRF vs WTEQF Comparison
MTHRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MTHRF stands at 9.3B. In comparison, WTEQF has a market cap of 0. Regarding current trading prices, MTHRF is priced at $13.65, while WTEQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MTHRF currently has a P/E ratio of 33.29, whereas WTEQF's P/E ratio is 1.78. In terms of profitability, MTHRF's ROE is +0.09%, compared to WTEQF's ROE of N/A. Regarding short-term risk, MTHRF is more volatile compared to WTEQF. This indicates potentially higher risk in terms of short-term price fluctuations for MTHRF.